CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 39 filers reported holding CERULEAN PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $31,000 | -31.1% | 44,255 | +3.5% | 0.00% | – |
| Q3 2016 | $45,000 | -50.5% | 42,773 | -0.1% | 0.00% | – |
| Q2 2016 | $91,000 | -22.9% | 42,830 | -1.9% | 0.00% | – |
| Q1 2016 | $118,000 | -10.6% | 43,643 | -7.5% | 0.00% | – |
| Q4 2015 | $132,000 | -21.0% | 47,201 | +3.5% | 0.00% | – |
| Q3 2015 | $167,000 | -1.2% | 45,605 | +24.5% | 0.00% | – |
| Q2 2015 | $169,000 | – | 36,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $6,970,000 | 7.48% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,047,000 | 5.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $954,000 | 0.25% |
| Deer VII & Co. Ltd. | 166,675 | $353,000 | 0.16% |
| Rock Springs Capital Management LP | 625,000 | $1,325,000 | 0.10% |
| Granahan Investment Management | 708,215 | $1,501,000 | 0.06% |
| Northeast Financial Consultants Inc | 20,000 | $42,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 202,623 | $430,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $34,000 | 0.01% |
| Alyeska Investment Group, L.P. | 319,289 | $677,000 | 0.01% |